- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Company Profile for Zogenix Inc (ZGNX)
Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.
Contact Information
Zogenix Inc
12671 High Bluff Drive
Suite 200
San Diego, CA 92130
United States
Key Executives for Zogenix Inc (ZGNX)
| Roger L HawleyCEO/Co-Founder | Stephen J FarrPresident |
| Cynthia Y RobinsonChief Development Officer | Ann D RhoadsExec VP/CFO/Treasurer/Secy |
| Richard Scott ShivelyExec VP/Chief Commercial Ofcr | John J TuraninVP/General Mgr:Zogenix Tech |
| Bret E MegargelVP:Corporate Dev/Co-Founder | Stephen H JennerVP:Marketing |
| Edward F Smith IIIVP:Regulatory Affairs & Drug | Mark R ThompsonVP:Sales & Managed Markets |
| Jeff D DurflingerVP:Technical Ops & Product Supply |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page